Increased derived neutrophil-to-lymphocyte ratio and Breast Imaging-Reporting and Data System classification predict poor survival in patients with non-distant metastatic HER2+ breast cancer treated with neoadjuvant chemotherapy

References

• FanLStrasser-WeipplKLiJJBreast cancer in ChinaLancet Oncol2014157e279e28924872111
   PubMed Web of Science ®Google Scholar
• ZhuXYingJWangFWangJYangHEstrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status in invasive breast cancer: a 3,198 cases study at National Cancer Center, ChinaBreast Cancer Res Treat2014147355155525234844
   PubMed Web of Science ®Google Scholar
• SparanoJAGrayRJMakowerDFProspective Validation of a 21-Gene Expression Assay in Breast CancerN Engl J Med2015373212005201426412349
   PubMed Web of Science ®Google Scholar
• AliHRProvenzanoEDawsonSJAssociation between CD8+ T-cell infiltration and breast cancer survival in 12,439 patientsAnn Oncol20142581536154324915873
   PubMed Web of Science ®Google Scholar
• MuenstSSoysalSDGaoFObermannECOertliDGillandersWEThe presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancerBreast Cancer Res Treat2013139366767623756627
   PubMed Web of Science ®Google Scholar
• MahmoudSMPaishECPoweDGAn evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancerBreast Cancer Res Treat201112719910820556505
   PubMed Web of Science ®Google Scholar
• LiuCHuangZWangQUsefulness of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in hormone-receptor-negative breast cancerOnco Targets Ther201694653466027536129
   PubMed Web of Science ®Google Scholar
• KohCHBhoo-PathyNNgKLUtility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancerBr J Cancer2015113115015826022929
   PubMed Web of Science ®Google Scholar
• YaoMLiuYJinHPrognostic value of preoperative inflammatory markers in Chinese patients with breast cancerOnco Targets Ther201471743175225328407
   PubMed Web of Science ®Google Scholar
• NohHEommMHanAUsefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patientsJ Breast Cancer2013161555923593082
   PubMed Web of Science ®Google Scholar
• YamagishiTFujimotoNNishiHPrognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesotheliomaLung Cancer201590111111726259877
   PubMed Web of Science ®Google Scholar
• SpolveratoGMaqsoodHKimYNeutrophil-lymphocyte and platelet-lymphocyte ratio in patients after resection for hepato-pancre-atico-biliary malignanciesJ Surg Oncol2015111786887425865111
   PubMed Web of Science ®Google Scholar
• PengBWangYHLiuYMMaLXPrognostic significance of the neutrophil to lymphocyte ratio in patients with non-small cell lung cancer: a systemic review and meta-analysisInt J Clin Exp Med2015833098310626064198
   PubMed Web of Science ®Google Scholar
• FerrucciPFGandiniSBattagliaABaseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patientsBr J Cancer2015112121904191026010413
   PubMed Web of Science ®Google Scholar
• PinatoDJShinerRJSecklMJStebbingJSharmaRMauriFAPrognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancerBr J Cancer201411081930193524667648
   PubMed Web of Science ®Google Scholar
• PistelliMDe LisaMBallatoreZPre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patientsBMC Cancer20151519525884918
   PubMed Web of Science ®Google Scholar
• StotzMGergerAEisnerFIncreased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancerBr J Cancer2013109241642123799847
   PubMed Web of Science ®Google Scholar
• LorenteDMateoJTempletonAJBaseline neutrophil-lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid useAnn Oncol201526475075525538172
   PubMed Web of Science ®Google Scholar
• KinoshitaAOnodaHImaiNComparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinomaBr J Cancer2012107698899322878374
   PubMed Web of Science ®Google Scholar
• LiMXLiuXMZhangXFPrognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysisInt J Cancer2014134102403241324122750
   PubMed Web of Science ®Google Scholar
• LiuCWuSMengXPredictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapyOncotarget2017826434274343828624781
   PubMedGoogle Scholar
• Xin-JiZYong-GangLXiao-JunSXiao-WuCDongZDa-JianZThe prognostic role of neutrophils to lymphocytes ratio and platelet count in gastric cancer: A meta-analysisInt J Surg201521849126225826
   PubMed Web of Science ®Google Scholar
• CummingsMMeroneLKeebleCPreoperative neutrophil: lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survivalBr J Cancer2015113231132026079303
   PubMed Web of Science ®Google Scholar
• SongSLiCLiSGaoHLanXXueYDerived neutrophil to lymphocyte ratio and monocyte to lymphocyte ratio may be better biomarkers for predicting overall survival of patients with advanced gastric cancerOnco Targets Ther2017103145315428706446
   PubMed Web of Science ®Google Scholar
• FerrucciPFAsciertoPAPigozzoJBaseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumabAnn Oncol201627473273826802161
   PubMed Web of Science ®Google Scholar
• GrenaderTNashSPlotkinYDerived neutrophil lymphocyte ratio may predict benefit from cisplatin in the advanced biliary cancer: the ABC-02 and BT-22 studiesAnn Oncol20152691910191626037798
   PubMed Web of Science ®Google Scholar
• DengQHeBLiuXPrognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive modelJ Transl Med2015136625885254
   PubMed Web of Science ®Google Scholar
• AbsengerGSzkanderaJPichlerMA derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patientsBr J Cancer2013109239540023820252
   PubMed Web of Science ®Google Scholar
• DalpiazOLuefTSelesMCritical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinomaBr J Cancer20171161859027907929
   PubMed Web of Science ®Google Scholar
• RussoAFranchinaTRicciardiGRRBaseline neutrophilia, derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or DocetaxelJ Cell Physiol20182331063376343
   PubMed Web of Science ®Google Scholar
• YangJCRischEZhangMHuangCHuangHLuLAssociation of tRNA methyltransferase NSUN2/IGF-II molecular signature with ovarian cancer survivalFuture Oncol201713221981199028829218
   PubMed Web of Science ®Google Scholar
• LuLBaiYWangZElevated T cell activation score is associated with improved survival of breast cancerBreast Cancer Res Treat2017164368969628488141
   PubMed Web of Science ®Google Scholar
• LiuCWangQSunBLow BMI is correlated with increased TGF-β and IL-10 mRNA levels in the peripheral blood of breast cancer patientsIUBMB Life201870323724529405562
   PubMed Web of Science ®Google Scholar
• JiaWWuJJiaHThe Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer PatientsPLoS One20151011e014306126580962
   PubMed Web of Science ®Google Scholar
• LiuCWangWMengXAlbumin/globulin ratio is negatively correlated with PD-1 and CD25 mRNA levels in breast cancer patientsOnco Targets Ther2018112131213929899663
   PubMed Web of Science ®Google Scholar
• AllenMDJonesLJThe role of inflammation in progression of breast cancer: Friend or foe? (Review)Int J Oncol201547379780526165857
   PubMed Web of Science ®Google Scholar
• HattarKFranzKLudwigMInteractions between neutrophils and non-small cell lung cancer cells: enhancement of tumor proliferation and inflammatory mediator synthesisCancer Immunol Immunother201463121297130625186613
   PubMed Web of Science ®Google Scholar
• DiakosCICharlesKAMcMillanDCClarkeSJCancer-related inflammation and treatment effectivenessLancet Oncol20141511e493e50325281468
   PubMed Web of Science ®Google Scholar
• GayLJFelding-HabermannBContribution of platelets to tumour metastasisNat Rev Cancer201111212313421258396
   PubMed Web of Science ®Google Scholar
• MantovaniAAllavenaPSicaABalkwillFCancer-related inflammationNature2008454720343644418650914
   PubMed Web of Science ®Google Scholar
• De LarcoJEWuertzBRFurchtLTThe potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8Clin Cancer Res200410154895490015297389
   PubMed Web of Science ®Google Scholar
• TaoHMimuraYAoeKPrognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cellsLung Cancer20127519510121719142
   PubMed Web of Science ®Google Scholar
• ShaoSRischEBurnerDLuLMinevBMaWIFNγ enhances cytotoxic efficiency of the cytotoxic T lymphocytes against human glioma cellsInt Immunopharmacol20174715916528410529
   PubMed Web of Science ®Google Scholar
• Arias-PulidoHCimino-MathewsAChaherNThe combined presence of CD20+B cells and PD-L1+tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcomeBreast Cancer Res Treat2018171227328229858752
   PubMed Web of Science ®Google Scholar
• CoxSHurtCGrenaderTMukherjeeSBridgewaterJCrosbyTThe prognostic value of derived neutrophil to lymphocyte ratio in oesopha-geal cancer treated with definitive chemoradiotherapyRadiother Oncol2017125115415928893415
   PubMed Web of Science ®Google Scholar
• Krenn-PilkoSLangsenlehnerUStojakovicTThe elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patientsTumour Biol201637136136826219894
   PubMedGoogle Scholar
• DiricanAKucukzeybekBBAlacaciogluADo the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?Int J Clin Oncol2015201708124532163
   PubMed Web of Science ®Google Scholar
• YingHQDengQWHeBSThe prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patientsMed Oncol2014311230525355641
   PubMed Web of Science ®Google Scholar
• ProctorMJMcMillanDCMorrisonDSFletcherCDHorganPGClarkeSJA derived neutrophil to lymphocyte ratio predicts survival in patients with cancerBr J Cancer2012107469569922828611
   PubMed Web of Science ®Google Scholar